Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
C4x Discovery Holdings Plc LSE:C4XD London Ordinary Share GB00BQQ2RV18 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.35 -1.97% 17.40 17.30 17.50 17.50 17.30 17.50 36,754 16:35:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -5.9 -2.0 - 44

C4x Discovery Share Discussion Threads

Showing 2776 to 2800 of 2850 messages
Chat Pages: 114  113  112  111  110  109  108  107  106  105  104  103  Older
DateSubjectAuthorDiscuss
13/7/2022
18:26
https://www.proactiveinvestors.co.uk/companies/news/987147/c4x-discovery-on-3m-sanofi-milestone-payment-and-pipeline-of-other-partnerships-987147.html
bloomberg2
11/7/2022
10:36
Nice move up today
bloomberg2
06/7/2022
07:46
In a decent market that symbolic payment would have seen the shares flying. It means they are progressing and cicra £2.7m for the pot. This one is a potential long term cash cow and one to watch!
alloa2003
06/7/2022
06:19
Dixi comes out fighting
bloomberg2
06/7/2022
06:14
RNS:C4X Discovery receives first milestone payment from Sanofi €3 million milestone payment triggered by pre-clinical progression in oral IL-17A inhibitor programme
livewireplus
04/7/2022
12:30
Dixi !! Get your finger out quick
bloomberg2
02/7/2022
10:18
In Dixi we trust !! We. Hope :)
bloomberg2
29/6/2022
21:09
INDV-2000 I believe, should be due any day now
ddonaldson2
29/6/2022
20:57
toxicology data for what?
davemac3
29/6/2022
16:33
Bear markets are cruel !! Will be painful if toxicology data is pants
bloomberg2
29/6/2022
10:23
What is happening here? Looks like the company is slowly dying but behind the scenes negotiations continue on licence deals. I hope funding doesnt become an issue before they sign a deal - looking that way with the share price.
alloa2003
10/6/2022
10:10
Keeping the faith and adding at these prices
ddonaldson2
10/6/2022
07:17
Keeping the faith ....in Dixi we trust
bloomberg2
09/6/2022
09:07
Final toxicology study for INDV-2000 due around the end of Q2 this year, the MAD study will be reinitiated in Q3. Likely to see more royalties this year? Also we have the commercial discussions in advanced stages hoping for a good second half of the year
ddonaldson2
29/4/2022
09:16
Might top up before the herd
bloomberg2
29/4/2022
06:41
Great interview - not sure why the market isnt taking all of this in.
alloa2003
28/4/2022
17:06
https://www.proactiveinvestors.co.uk/companies/news/980874/c4x-discovery-holdings-plc-on-expanding-its-portfolio-980874.html
bloomberg2
28/4/2022
14:38
Only 1 x 7,000 trade today thus far. Terrible corporate pr given the unfolding story
t0pgrader
28/4/2022
13:25
Did anyone catch the results presentation? I've seen the slides on the website but missed the webcast. Anything interesting?
bamboozler
28/4/2022
08:16
You have hit the nail on the head - a point I have mentioned a few times. When people see these huge numbers they think that is it, they dont even see the single digit royalties which are on top of the potential payment figures mentioned.

As the C4XD system is basically reformulating and improving existing treatments for oral use, there is little chance of the molecule being rejected at the regulatory stage. Therefore it doesnt take much to see how very quickly this company could turn into a HUGE cash cow, funding not only future funding but, eventually, dividends for shareholders. Yet another untapped and ignored potential gem in my view.

alloa2003
28/4/2022
07:45
Advanced commercial discussions with multiple potential partners for NRF2 activator programme for inflammatory diseases with pre-candidate nomination, preliminary safety and efficacy studies completed.This certainly paints the right picture but I thought there may be more updates on the Sanofi deal which was announced. Under the terms of the agreement, C4XD will receive an upfront payment of €7 million and could receive up to a further €407 million in potential development, regulatory and commercialisation milestones, of which €11 million is in pre-clinical milestones, in addition to single digit royalties.
copandrobber
28/4/2022
07:39
I agree but hoped he'll add a bit more meat to the bone on the call at 10am
copandrobber
28/4/2022
06:22
While the figures are irrelevant at this stage, todays half year results contain some very very encouraging comments on milestones and future potential partnership deals. They may be taking their time but history shows they can deliver potentially huge deals.
alloa2003
27/4/2022
13:24
Also, the company doesnt seem to be "leaky" when it comes to announcements. I remember the shock fund raising at a 50% discount to the share price. Nobody saw that coming, not even the company - who had previously agreed a much higher price!

Final thought. If, as we assume, there is at least one potentially huge deal just around the corner (and other milestones to come), why would the company look to raise funds before the big bounce? Surely if they had to raise funds they would do it in tandem with good news?

alloa2003
27/4/2022
13:15
I have just bought a few more. As long as there is no fundraising tomorrow, I cant see them staying at this level for too long. I think this move down was caused by a badly handled sale order a few weeks ago but the INDV announcement probably didnt help.
alloa2003
Chat Pages: 114  113  112  111  110  109  108  107  106  105  104  103  Older
Your Recent History
LSE
C4XD
C4x Discov..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230205 18:05:33